November 18, 2026
Health news, explained with evidence
LIVE
CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee

New Analysis Finds No Link Between Gout Flares and Cardiovascular Events

🥗 Nutrition 2 min read 👁 4

A secondary analysis of the CARES trial indicates that gout flares do not increase the risk of cardiovascular events in patients undergoing urate-lowering therapy.

New Analysis Finds No Link Between Gout Flares and Cardiovascular Events🥗Nutrition

Photo: medpagetoday.com

Key points

  • Secondary analysis of the CARES trial shows no link between gout flares and cardiovascular events.
  • The study population consisted of patients at high risk for cardiovascular disease receiving urate-lowering therapy.
  • Results remained consistent across multiple subgroup analyses and flare definitions.

A recent secondary analysis of the randomized CARES trial has found no evidence of an association between gout flares and subsequent cardiovascular events among patients receiving treat-to-target urate-lowering therapy. The findings, presented at the American College of Rheumatology annual meeting, suggest that the inflammation caused by acute gout flares does not necessarily trigger major adverse cardiovascular events (MACE) in this specific clinical population.

Researchers examined data from the CARES trial, which focused on patients with known cardiovascular disease or significant risk factors. Participants were randomized to receive either allopurinol or febuxostat, with dosages adjusted to reach specific urate targets. By comparing over 650 patients who experienced MACE against more than 3,200 controls, the study found no increased odds of gout flares among those who suffered cardiovascular events.

What to know: While previous observational research suggested a potential link between gout flares and heart health, this study provides reassurance for clinicians using standard gout management protocols. The analysis remained consistent across various sensitivity checks, including different definitions of gout flares and periods of intense treatment initiation.

The findings suggest that clinicians can continue to recommend treat-to-target urate-lowering therapy without the concern that these flares are inducing cardiovascular events.

Patients should always consult with their healthcare provider to discuss their specific cardiovascular risk profile and appropriate gout management strategies. Further research is needed to reconcile these findings with earlier observational data and to better understand the complex relationship between anti-inflammatory medications and cardiovascular outcomes.

Source medpagetoday.com — medpagetoday.com/meetingcoverage/acrvideopearls/123944 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.